Moderna and Merck’s Melanoma Breakthrough | Duluth News

Duluth News Today | 2 Min News | The Daily News Now! · Aug 20, 2026 · 1m

Moderna and Merck just dropped a game-changing update: their personalized melanoma vaccine, Intismeran, is showing stunning results in Phase Three trials—dramatically slashing cancer recurrence rates by tailoring mRNA tech to each patient’s tumor mutations, paired with Keytruda, offering new hope for those who’ve beaten melanoma and fear it might return. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View…